Cardiorenal syndrome: understanding the connections between cardiac and renal disease

Kate Andrukonis1, Caroline Bell, Lisa Bodine

  • 1Kate Andrukonis practices emergency medicine at Alamance Regional Medical Center in Burlington, N.C. Caroline Bell practices at Salem Chest Specialists in Winston-Salem, N.C. Lisa Bodine practices at Family Medicine Associates of Alexandria, Va. Emily H. McDowell practices internal medicine at Huntingdon Medical Foundation in Pasadena, Calif. Suzanne Reich practices family medicine at Wake Forest School of Medicine in Winston-Salem, N.C. Ms. Reich and Tanya Gregory are assistant professors in the Department of Physician Assistant Studies at Wake Forest School of Medicine. The authors have indicated no relationships to disclose relating to the content of this article.

Insights

Cardiorenal syndrome, a classification for heart and kidney disease interplay, was recently developed. This framework aids in managing complex patients and guides future research in cardiorenal medicine.

Area of Science:

  • Nephrology and Cardiology
  • Cardiorenal Medicine

Background:

  • Renal and cardiac diseases are prevalent in hospitalized and outpatient populations.
  • The clinical interplay between the heart and kidneys is increasingly recognized.
  • A formal classification for cardiorenal interactions has been recently established.

Purpose of the Study:

  • To introduce the concept and classification of cardiorenal syndrome.
  • To provide a framework for understanding the relationship between cardiac and renal systems.
  • To guide clinical management and future research in cardiorenal medicine.

Main Methods:

  • The abstract does not specify methods, but discusses the development of a classification system.
  • Literature review and expert consensus likely informed the classification.

Main Results:

  • Cardiorenal syndrome was formally described by Claudio Ronco in 2008.
  • This classification provides a structured approach to cardiorenal disease.

Conclusions:

  • The cardiorenal syndrome classification is essential for managing patients with combined heart and kidney conditions.
  • It serves as a foundation for advancing research in cardiorenal pathophysiology and therapeutics.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K